Abstract:Apart from their activity in combating infections, neutrophils play an important role in regulating the tumor microenvironment. Neutrophils can directly kill (antibody-coated) cancer cells, and support other immune anti-tumoral strategies. On the other hand, neutrophils can also exert pro-tumorigenic activities <i>via</i> the production of factors which promote cancer growth, angiogenesis and metastasis formation. The balance of anti- and pro-cancer activity is influenced by the particularly delicate interplay that exists between neutrophils and T lymphocytes. In murine models, it has been reported that γδ T cells are a major source of IL-17 that drives the recruitment and pro-tumorigenic differentiation of neutrophils. This, however, contrasts with the well-studied anti-tumor activity of γδ T cells in experimental models and the anti-tumor activity of human γδ T cells. In this article, we first review the reciprocal interactions between neutrophils, tumor cells and T lymphocytes with a special focus on their interplay with γδ T cells, followed by the presentation of our own recent results. We have previously shown that zoledronic acid (ZOL)-activated neutrophils inhibit γδ T-cell proliferation due to the production of reactive oxygen species, arginase-1 and serine proteases. We now demonstrate that killing of ductal pancreatic adenocarcinoma (PDAC) cells by freshly isolated resting human γδ T cells was reduced in the presence of neutrophils and even more pronounced so after activation of neutrophils with ZOL. In contrast, direct T-cell receptor-dependent activation by γδ T cell-specific pyrophosphate antigens or by bispecific antibodies enhanced the cytotoxic activity and cytokine/granzyme B production of resting human γδ T cells, thereby overriding the suppression by ZOL-activated neutrophils. Additionally, the coculture of purified neutrophils with autologous short-term expanded γδ T cells enhanced rather than inhibited γδ T-cell cytotoxicity against PDAC cells. Purified neutrophils alone also exerted a small but reproducible lysis of PDAC cells which was further enhanced in the presence of γδ T cells. The latter set-up was associated with improved granzyme B and IFN-γ release which was further increased in the presence of ZOL. Our present results demonstrate that the presence of neutrophils can enhance the killing capacity of activated γδ T cells. We discuss these results in the broader context of regulatory interactions between neutrophils and T lymphocytes.

Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells

Rational targeting of immunosuppressive neutrophils in cancer

Neutrophils in Cancer immunotherapy: friends or foes?

Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis

Neutrophils in cancer: dual roles through intercellular interactions

Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential

Interactions between γδ T cells and neutrophils in cancer: Knowns and unknowns

Tumor-associated neutrophils and neutrophil-targeted cancer therapies

Tumor Associated Neutrophils Promote the Metastasis of Pancreatic Ductal Adenocarcinoma

γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells

A neutrophil response linked to tumor control in immunotherapy

Tumor Induced PD-L1 on Neutrophils Suppress the Antitumor Immunity of NK Cells Via PD-L1/PD-1 Axis

Role of Neutrophils on Cancer Cells and Other Immune Cells in the Tumor Microenvironment

Targeting and Exploitation of Tumor-Associated Neutrophils to Enhance Immunotherapy and Drug Delivery for Cancer Treatment

Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal

Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer

Interplay between tumor-derived factors and tumor-associated neutrophils: opportunities for therapeutic interventions in cancer

Neutrophil dynamics in the tumor microenvironment determines therapy efficacy and is regulated by microbiota

Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.

A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression